Compare ACON & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACON | INBS |
|---|---|---|
| Founded | 2008 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 6.5M |
| IPO Year | 2022 | 2019 |
| Metric | ACON | INBS |
|---|---|---|
| Price | $2.42 | $1.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 43.8K | ★ 47.2K |
| Earning Date | 11-11-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.82 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $75,730.00 | ★ $1,980,484.00 |
| Revenue This Year | $78.26 | $44.72 |
| Revenue Next Year | $90.37 | $44.26 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 65.62 | N/A |
| 52 Week Low | $1.95 | $0.54 |
| 52 Week High | $12.03 | $24.90 |
| Indicator | ACON | INBS |
|---|---|---|
| Relative Strength Index (RSI) | 49.50 | 33.48 |
| Support Level | $2.33 | $1.52 |
| Resistance Level | $2.50 | $2.45 |
| Average True Range (ATR) | 0.18 | 0.13 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 22.95 | 13.79 |
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.